Abstract:Malaria is an infectious disease that affects over 216 million people worldwide, killing over 445,000 patients annually. Due to the constant emergence of parasitic resistance to the current antimalarial drugs, the discovery of new drug candidates is a major global health priority. Aiming to make the drug discovery processes faster and less expensive, we developed binary and continuous Quantitative Structure-Activity Relationships (QSAR) models implementing deep learning for predicting antiplasmodial activity and cytotoxicity of untested compounds. Then, we applied the best models for a virtual screening of a large database of chemical compounds. The top computational predictions were evaluated experimentally against asexual blood stages of both sensitive and multi-drug-resistant Plasmodium falciparum strains. Among them, two compounds, LabMol-149 and LabMol-152, showed potent antiplasmodial activity at low nanomolar concentrations (EC50 <500 nM) and low cytotoxicity in mammalian cells. Therefore, the computational approach employing deep learning developed here allowed us to discover two new families of potential next generation antimalarial agents, which are in compliance with the guidelines and criteria for antimalarial target candidates.Malaria is a serious infectious disease caused by parasites of the genus Plasmodium. The recommended treatment is a combination of antimalarial drugs. However, the rise of parasites resistant to the current antimalarial drugs means that new therapeutics are continually required. To meet this challenge, we developed and applied models using deep learning, a powerful artificial intelligence method, supported by experimental validation to identify new drug candidates against malaria. We used the developed computational models to prioritize novel, active, and nontoxic compounds from virtual chemical libraries for experimental evaluation. Then, the predicted antimalarial compounds were experimentally validated in assays on Plasmodium falciparum culture. This allowed us to discover two new potential antimalarial candidates. The use of computational approaches is an attractive route to expedite the discovery of new therapeutics, especially to infectious tropical diseases, as it can reduce time and development costs. Future directions include in vivo studies on animal models.

Bayesian Data Integration and Enrichment Analysis for Predicting Gene Function in Malaria

Gene function prediction using semantic similarity clustering and enrichment analysis in the malaria parasite Plasmodium falciparum

Enhancing Gene Co-expression Network Inference for the Malaria Parasite Plasmodium falciparum

From Genome-Scale Data to Models of Infectious Disease: A Bayesian Network-Based Strategy to Drive Model Development

A systems-level gene regulatory network model for Plasmodium falciparum

Co-expression network with protein-protein interaction and transcription regulation in malaria parasite Plasmodium falciparum.

Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle

Computational approach for decoding malaria drug targets from single-cell transcriptomics and finding potential drug molecule

In silico gene function prediction using ontology-based pattern identification

The Development of Machine Learning Methods in Discriminating Secretory Proteins of Malaria Parasite

Functional Proteome and Expression Analysis of Sporozoites and Hepatic Stages of Malaria Development

Antimalarial Drug Predictions Using Molecular Descriptors and Machine Learning against Plasmodium Falciparum

Identification and Functional Validation of the Novel Antimalarial Resistance Locus PF10_0355 in Plasmodium falciparum

Strong positive selection biases identity-by-descent-based inferences of recent demography and population structure in Plasmodium falciparum

MalariaSED: a deep learning framework to decipher the regulatory contributions of noncoding variants in malaria parasites

Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?

Deep Learning-driven research for drug discovery: Tackling Malaria

Transcriptome-based analysis of blood samples reveals elevation of DNA damage response, neutrophil degranulation, cancer and neurodegenerative pathways in Plasmodium falciparum patients

Application of barcode sequencing to increase the throughput and complexity of Plasmodium falciparum genetic screening

Malaria Parasite Detection on Microscopic Blood Smear Images with Integrated Deep Learning Algorithms